GOG-0241 Recurrent Gynecologic Cancer - On Study Form (OSR) Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder:

  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Fallopian Tube Cancer NCT01081262 On-Study - GOG-0241 Recurrent Gynecologic Cancer - On Study Form (OSR) - 3127560v1.0

No Instruction available.

  1. StudyEvent: GOG-0241 Recurrent Gynecologic Cancer - On Study Form (OSR)
    1. No Instruction available.
Header Module
Disease Description - Prior History
Stage (at diagnosis FIGO)
Primary Surgery Type (check all that apply)
Disease Description - Current History
Current Status of Disease
What was the method used to determine recurrence or progression
Site(s) of disease at study entry (check all that apply)
Prior Treatment For Gynecologic Cancer
Prior Systemic Chemotherapy
Chemotherapy Regimen
Prior Hormonal Therapy
Non-protocol biologic response modifier?
Prior Radiation Therapy
Is the site of recurrence within the field previously treated by radiation therapy?
Comments Module

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial